Glycopyrrolate combinations for the treatment of respiratory diseases

Abstract

This paper analyses three patents, published in 2005 by Sofotec GmbH & Co. KG, for the treatment of respiratory diseases that include asthma and chronic obstructive pulmonary disease (COPD). The patent applications claim the combination of anticholinergics and different bronchodilators or anti-inflamatories as β-mimetics, PDE4 inhibitors and glucocorticoids.

Keywords::

• anticholinergic
• asthma
• chronic obstructive pulmonary disease (COPD)
• glucocorticoid
• glycopyrrolate
• long-acting β-agonist (LABA)
• PDE4 inhibitor

Patent Details

• Title Novel combination of anticholinergic and inhibitors of phosphodiesterase Type 4 for the treatment of respiratory diseases

• Assignee Sofotec GmbH & Co. KG

• Inventors Goede J, Maus J, Cnota PJ, Szelenyl I

• Priority data 06/02/2004

• Filing date 07/02/2005

• Publication date 11/08/2005

• Publication no. US20050175547

• Title Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD

• Assignee Sofotec GmbH & Co. KG

• Inventors Goede J, Maus J, Cnota PJ, Szelenyl I

• Priority data 06/02/2004

• Filing date 07/02/2005

• Publication date 11/08/2005

• Publication no. US20050175548

• Title Novel combination of anticholinergic and SS mimetics for the treatment of respiratory diseases

• Assignee Sofotec GmbH & Co. KG

• Inventors Goede J, Maus J, Cnota PJ, Szelenyl I

• Priority data 06/02/2004

• Filing date 07/02/2005

• Publication date 11/08/2005

• Publication no. US20050175549